Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PHIO

Phio Pharmaceuticals Corp

May 06 • 04:00PM ET

1.15

+0.02 1.77 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: GTBP AEON DRMA BCLI BTAI SNGX ALZN QNRX REGN VRTX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.50	Insider Own	10.62%	Shs Outstand	11.62M	Perf Week	-2.54%
Market Cap	13.36M	Forward P/E	-	EPS next Y	-0.62	Insider Trans	1.65%	Shs Float	10.38M	Perf Month	-7.26%
Enterprise Value	-7.67M	PEG	-	EPS next Q	-0.23	Inst Own	3.07%	Short Float	5.01%	Perf Quarter	24.32%
Income	-8.70M	P/S	-	EPS this Y	34.48%	Inst Trans	3.08%	Short Ratio	0.14	Perf Half Y	-38.17%
Sales	0.00M	P/B	0.66	EPS next Y	34.74%	ROA	-63.90%	Short Interest	0.52M	Perf YTD	9.52%
Book/sh	1.73	P/C	0.64	EPS next 5Y	-	ROE	-69.95%	52W High	4.19 -72.55%	Perf Year	-33.14%
Cash/sh	1.81	P/FCF	-	EPS past 3/5Y	74.81% 62.91%	ROIC	-43.17%	52W Low	0.81 41.50%	Perf 3Y	-96.79%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.91% 4.21%	Perf 5Y	-99.51%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	85.44%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	16.03	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	43.16	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	16.03	EPS Q/Q	78.24%	SMA20	-5.93%	Beta	0.84	Target Price	14.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-4.99%	Rel Volume	0.04	Prev Close	1.13
Employees	6	LT Debt/Eq	0.00	Earnings	Mar 05 AMC	SMA200	-26.84%	Avg Volume	3.76M	Price	1.15
IPO	May 10, 2012	Option/Short	No / Yes	EPS/Sales Surpr.	55.88% -	Trades		Volume	146,903	Change	1.77%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)